Patent ID: 11857538
Assignee: SOMERSET THERAPEUTICS, LLC
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A pharmaceutically acceptable and ophthalmologically suitable reduced buffer content composition in the form of a solution for treating an ocular condition via administration to a mammalian eye, the reduced buffer content composition comprising an effective amount of a pilocarpine compound, wherein the effective amount of the pilocarpine compound is an amount greater than about 1% w/v of the composition and wherein the pilocarpine compound is the only active pharmaceutical ingredient present in the composition, and an effective amount of a uniform buffering component, wherein the uniform buffering component is present in a concentration such that the concentration of the pilocarpine compound in the composition is at least 1.5 times the concentration of the buffering component in the composition and the concentration of the pilocarpine compound in the composition is less than 4 times the concentration of the buffering component in the composition.